| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2004 | WO2004033710A2 Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol |
| 04/22/2004 | WO2004033706A2 Nucleic acids encoding duramycin |
| 04/22/2004 | WO2004033704A1 Method of purifying lantibiotics |
| 04/22/2004 | WO2004033695A2 A promoter from streptomyces coelicolor |
| 04/22/2004 | WO2004033694A2 Promoter to il-18bp, its preparation and use |
| 04/22/2004 | WO2004033690A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | WO2004033689A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 04/22/2004 | WO2004033688A1 Cap-binding protein |
| 04/22/2004 | WO2004033687A1 Method of screening remedy for renal failure |
| 04/22/2004 | WO2004033686A1 Novel protein and dna thereof |
| 04/22/2004 | WO2004033685A1 Single chain recombinant t cell receptors |
| 04/22/2004 | WO2004033682A1 Process for producing hyperthermostable endoglucanase |
| 04/22/2004 | WO2004033681A1 Substance having activity of promoting platelet aggregation |
| 04/22/2004 | WO2004033672A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | WO2004033666A2 Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases |
| 04/22/2004 | WO2004033664A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/22/2004 | WO2004033663A2 Carbohydrate-based synthetic vaccines for hiv |
| 04/22/2004 | WO2004033661A2 Ferritin light subunit variant-encoding nucleic acids, polypeptides, transgenic animals, antibodies, and methods of use thereof |
| 04/22/2004 | WO2004033659A2 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 04/22/2004 | WO2004033657A2 Heat shock protein binding fragments of cd91, and uses thereof |
| 04/22/2004 | WO2004033655A2 Human organic solute transporters |
| 04/22/2004 | WO2004033651A2 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 04/22/2004 | WO2004033650A2 Diagnostic assay and related products |
| 04/22/2004 | WO2004033648A2 Isolated mammalian membrane protein genes; related reagents |
| 04/22/2004 | WO2004033647A2 Assay methods for state-dependent calcium channel agonists/antagonists |
| 04/22/2004 | WO2004033645A2 Methods of regulating body weight |
| 04/22/2004 | WO2004033642A2 Alpha 2hs glycoprotein for treatment of cancer and a method for preparation thereof |
| 04/22/2004 | WO2004033639A2 Targeting of herpes simplex virus to specific receptors |
| 04/22/2004 | WO2004033637A2 Extracellular messengers |
| 04/22/2004 | WO2004033636A2 Protein modification and maintenance molecules |
| 04/22/2004 | WO2004033634A2 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 04/22/2004 | WO2004033631A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/22/2004 | WO2004033627A2 Methods for efficient production of mammalian recombinant proteins |
| 04/22/2004 | WO2004033499A1 Cell death-inducing agent |
| 04/22/2004 | WO2004033498A2 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 04/22/2004 | WO2004033497A1 Mhc multimers |
| 04/22/2004 | WO2004033496A1 Agonists and antagonists of the human odorant receptor or17-4 and uses thereof |
| 04/22/2004 | WO2004033493A1 Human protein for promoting transformation of 3t3 cell and its coding sequence |
| 04/22/2004 | WO2004033492A1 A brittle-culm-controlling protein and gene encoding it and a method for changing brittleness of plant's stem |
| 04/22/2004 | WO2004033491A1 Insecticidal and/or nematicidal proteins |
| 04/22/2004 | WO2004033490A2 Hcmv derived immunomodulatory polypeptide |
| 04/22/2004 | WO2004033487A1 Protein lattice |
| 04/22/2004 | WO2004033486A2 Production of homotrimeric fusion proteins |
| 04/22/2004 | WO2004033483A2 Liposomal system and method of using same |
| 04/22/2004 | WO2004033481A2 Igf-binding protein-derived peptide or small molecule |
| 04/22/2004 | WO2004033471A2 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | WO2004032973A2 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases |
| 04/22/2004 | WO2004032958A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 04/22/2004 | WO2004032957A1 Immunization of non-human mammals against streptococcus equi |
| 04/22/2004 | WO2004032952A1 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032850A2 Uses of human zven antagonists |
| 04/22/2004 | WO2004032847A2 Hepatocyte growth factor variants |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032831A2 Metalization of microtubules |
| 04/22/2004 | WO2004032789A2 Liposomal hgh composition and method for administration thereof |
| 04/22/2004 | WO2004032615A1 Chimeric mouse with regulated bradeion gene expression |
| 04/22/2004 | WO2004032614A2 Animal with modification of cytoplasmic dynein heavy chain 1 gene |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2004027068A3 Systems for expressing toxic proteins, vectors and method of producing toxic proteins |
| 04/22/2004 | WO2004022657A8 Increasing of the resorption of substances via skin and mucous membranes |
| 04/22/2004 | WO2004018638A9 Iron transport and metabolism proteins |
| 04/22/2004 | WO2004017987A3 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 04/22/2004 | WO2004016649A3 Method for the production of an artificial polypeptide and artificial proteins produced by said method |
| 04/22/2004 | WO2004015395A3 Method for identifying mhc-presented peptide epitopes for t cells |
| 04/22/2004 | WO2004015099A3 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 04/22/2004 | WO2004009764A3 Methods and compositions concerning altered yellow fever virus strains |
| 04/22/2004 | WO2004007557A3 Tf antagonist |
| 04/22/2004 | WO2004005332A3 Secreted peptides |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003097680A3 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same |
| 04/22/2004 | WO2003097673B1 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
| 04/22/2004 | WO2003091385A3 Assay methods relating to the action of geminin in the licensing of dna replication complexes in transformed cells |
| 04/22/2004 | WO2003089452A3 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003086286A3 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 04/22/2004 | WO2003083102A3 Cancer associated protein phosphatases and their uses |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068798A3 Oligonucleotide analogues and methods of use for modulating gene expression |
| 04/22/2004 | WO2003060066A8 Nucleic acid delivery and expression |
| 04/22/2004 | WO2003059281A9 Novel variants of rankl protein |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003052082A3 Fusion partner cells and uses thereof |
| 04/22/2004 | WO2003048198A3 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003045998A3 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 04/22/2004 | WO2003045440A9 Regulation of hypoxia-inducible gene expression with antisense inhibitory pas domain protein |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003039346A8 Diagnostics and therapeutics for ocular abnormalities |
| 04/22/2004 | WO2003031642A3 lovE VARIANT REGULATOR MOLECULES |
| 04/22/2004 | WO2003031566A3 Keratinocyte derived interferon |
| 04/22/2004 | WO2003029428A8 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/22/2004 | WO2003029279A9 Immunodominant acetylcholine receptor alpha subunit peptide: mhc complexes |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2003020893A3 New adenovirus type 7 vectors |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003014308A9 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 04/22/2004 | WO2003012103A3 Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses |